Lisanti Capital Growth, LLC Amicus Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $1.87 Million - $4.86 Million	-203,755 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$13.47 - $24.89 $2.74 Million - $5.07 Million	203,755 New	203,755 $4.71 Million
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $1.15 Million - $1.5 Million	-87,495 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.2 Million - $1.5 Million	87,495 New	87,495 $1.32 Million

273

325M

841K

353K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.81B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.